Radiation DosageRadiation, IonizingAntineoplastic Combined Chemotherapy ProtocolsRadiation InjuriesAntineoplastic AgentsDose-Response Relationship, RadiationRadiation ToleranceRadiationChemotherapy, AdjuvantRadiation ProtectionRadiation MonitoringCombined Modality TherapyDoxorubicinCisplatinNeoplasmsCell Line, TumorRadiation OncologyDrug Screening Assays, AntitumorTreatment OutcomeRadiotherapyCosmic RadiationRadiation Injuries, ExperimentalDrug Resistance, NeoplasmBreast NeoplasmsRadiation PneumonitisEtoposideGamma RaysCyclophosphamideRadiotherapy DosageNeoplasms, Radiation-InducedApoptosisAntineoplastic Agents, PhytogenicPaclitaxelBackground RadiationCell SurvivalAntibiotics, AntineoplasticRadiation-Sensitizing AgentsDisease-Free SurvivalTime FactorsRadiometryNeoplasm StagingUltraviolet RaysSurvival AnalysisNeoadjuvant TherapyDNA DamageRadiation EffectsPrognosisLung NeoplasmsSurvival RateRadiation-Protective AgentsTumor Cells, CulturedRadiotherapy, AdjuvantVinblastineDose-Response Relationship, DrugDrug Administration ScheduleAntimetabolites, AntineoplasticMice, NudeXenograft Model Antitumor AssaysCamptothecinNeoplasm Recurrence, LocalMethotrexateDrug Delivery SystemsBleomycinCarboplatinOrganoplatinum CompoundsBrain NeoplasmsAntineoplastic Agents, AlkylatingAdenocarcinomaTaxoidsRadiotherapy, ConformalAcute Radiation SyndromeDose FractionationCell ProliferationDeoxycytidineDrug CarriersFollow-Up StudiesCarcinoma, Non-Small-Cell LungX-RaysCobalt RadioisotopesCarcinoma, Squamous CellRadioactive Hazard ReleaseP-GlycoproteinRadiotherapy, Intensity-ModulatedDrug Resistance, MultipleDNA RepairClinical Trials as TopicHead and Neck NeoplasmsAnthracyclinesDaunorubicinRadiobiologyRadiation Hybrid MappingOvarian NeoplasmsBrachytherapyCell CycleNeoplasm MetastasisDacarbazineDrug SynergismInduction ChemotherapyMitomycinTomography, X-Ray Computed